Prospective Screening Programme for Malignant Tumors

2020-01-22 12:12:55 | BioPortfolio


In prospective part of study, we have found that the parameters of routine blood tests can differentiate varieties of malignancy from healthy people.

We enrolled healthy subjects and patients with malignancy that aged from 18 to 85,and collected their clinical data and blood tests result to build the model.And retrospectlly enroll healthy subjects and patients to test the model.

Study Design


Hematologic Tests


Sun Yat-sen University Cancer Center


Active, not recruiting


Sun Yat-sen University

Results (where available)

View Results


Published on BioPortfolio: 2020-01-22T12:12:55-0500

Clinical Trials [412 Associated Clinical Trials listed on BioPortfolio]

A Trial of TTI-621 for Patients With Hematologic Malignancies

Multicenter, open-label, Phase 1a/1b trial of TTI-621 in subjects with relapsed or refractory hematologic malignancies.

Integrated Whole-Genome Analysis of Hematologic Disorders

To identify mutations, changes in DNA copy number, structural rearrangements, or altered microRNA/mRNA expression that are important for the initiation, progression, or treatment response ...

Repeat Dose Safety Study for Compound to Treat Hematologic Cancer

The purpose of this study is to characterize the safety and tolerability of repeat doses of compound GSK2110183 in subjects with hematologic cancer.

Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancer

The purpose of this study is to determine the highest feasible dose (HFD) of intravenous (IV) APR-246 when given to patients with refractory hematologic malignancies or prostate carcinoma.

Infusional C-Myb ASODN in Advanced Hematologic Malignancies

The purpose of this study is to evaluate whether C-myb Antisense (AS) Oligonucleotides (ODNs)is a possible treatment modality for advanced hematologic malignancies.

PubMed Articles [3568 Associated PubMed Articles listed on BioPortfolio]

Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.

Serum procalcitonin (PCT) and C-reactive protein (CRP) are biomarkers of infection. In patients with hematologic disorders with or without hematopoietic stem cell transplantation (HSCT), it is difficu...

Antifungal prophylaxis with posaconazole tablet and oral suspension in patients with hematologic malignancy: therapeutic drug monitoring, efficacy, and risk factors for the suboptimal level.

Posaconazole is used to prevent invasive fungal infections (IFIs) in patients with hematologic malignancy. In this study, we compared plasma posaconazole concentrations (PPCs) and the incidence of bre...

Pyoderma Gangrenosum in Hematologic Malignancies: Systematic Review.

Pyoderma gangrenosum (PG) is a devastating neutrophilic dermatosis that may be associated with trauma or systemic diseases. The associations, characteristics, and temporal relationship of PG with hema...

Clinical research in older adults with hematologic malignancies: Opportunities for alignment in the Veterans Affairs.

Management of hematologic malignancies in older patients is complex and, with recent and anticipated trends in demographics, increasingly common. As a large, nationally integrated medical system the V...

Days spent at home in the last 6 months of life: a quality indicator of end of life care in patients with hematologic malignancies.

Despite advances in the management of hematologic malignancies, a significant proportion of patients die of their disease. We used administrative databases in Ontario, Canada (between 2005 and 2013) t...

Medical and Biotech [MESH] Definitions

Tests used in the analysis of the hemic system.

The co-occurrence of pregnancy and a blood disease (HEMATOLOGIC DISEASES) which involves BLOOD CELLS or COAGULATION FACTORS. The hematologic disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.

Standardized tests designed to measure abilities, as in intelligence, aptitude, and achievement tests, or to evaluate personality traits.

Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests.

An array of tests used to determine the toxicity of a substance to living systems. These include tests on clinical drugs, foods, and environmental pollutants.

More From BioPortfolio on "Prospective Screening Programme for Malignant Tumors"

Quick Search

Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Searches Linking to this Trial